Allogeneic hematopoietic stem cell transplantation recipient
Clinical trials for Allogeneic hematopoietic stem cell transplantation recipient explained in plain language.
Never miss a new study
Get alerted when new Allogeneic hematopoietic stem cell transplantation recipient trials appear
Sign up with your email to follow new studies for Allogeneic hematopoietic stem cell transplantation recipient, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo shows promise for Post-Transplant leukemia relapse
Disease control CompletedThis phase 1 trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 29 patients whose acute myeloid leukemia or myelodysplastic syndrome came back or did not respond after a donor stem cell transplant. The goal was to find the safest dose and see if the drugs could he…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Vitamin a boost before stem cell transplant may shield the gut
Prevention CompletedThis trial tests whether a single high dose of vitamin A, given before a donor stem cell transplant, can prevent gastrointestinal graft-versus-host disease (GVHD), a condition where donor cells attack the gut. Vitamin A deficiency is linked to a higher risk of this complication, …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC